Evidence map›Paper›PMID 26236095›Full record

ArticleJournal of clinical biochemistry and nutrition2015

Manganese superoxide dismutase promotes interaction of actin, S100A4 and Talin, and enhances rat gastric tumor cell invasion.

Hiroko P Indo, Hirofumi Matsui, Jing Chen, Haining Zhu, Clare L Hawkins, Michael J Davies, Chontida Yarana, Daret K St Clair, Hideyuki J Majima

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical biochemistry and nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. MiR-296-5p ameliorates deep venous thrombosis by inactivating S100A4.Experimental biology and medicine (Maywood, N.J.) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Hiroko P IndoDepartment of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan ; Graduate Center for Toxicology, University of Kentucky, BBSRB Building 741 S. Limestone, B278 and 306 Health Sciences Research Building, 1095 V.A. Drive, Lexington, KY 40536, USA.
Hirofumi MatsuiDivision of Gastroenterology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Ten-noudai, Tsukuba, Ibaraki 305-8577, Japan.
Jing ChenDepartment of Molecular & Cellular Biochemistry and Center for Structural Biology, University of Kentucky, BBSRB Building 741 S. Limestone, B278 and 306 Health Sciences Research Building, 1095 V.A. Drive, Lexington, KY 40536, USA.
Haining ZhuDepartment of Molecular & Cellular Biochemistry and Center for Structural Biology, University of Kentucky, BBSRB Building 741 S. Limestone, B278 and 306 Health Sciences Research Building, 1095 V.A. Drive, Lexington, KY 40536, USA.
Clare L HawkinsThe Heart Research Institute, 7 Eliza Street, Newtown, Sydney, NSW 2042, Australia ; Faculty of Medicine, Sydney Medical School, The University of Sydney, Edward Ford Building A27, Sydney, NSW 2006, Australia.
Michael J DaviesThe Heart Research Institute, 7 Eliza Street, Newtown, Sydney, NSW 2042, Australia ; Faculty of Medicine, Sydney Medical School, The University of Sydney, Edward Ford Building A27, Sydney, NSW 2006, Australia.
Chontida YaranaGraduate Center for Toxicology, University of Kentucky, BBSRB Building 741 S. Limestone, B278 and 306 Health Sciences Research Building, 1095 V.A. Drive, Lexington, KY 40536, USA.
Daret K St ClairGraduate Center for Toxicology, University of Kentucky, BBSRB Building 741 S. Limestone, B278 and 306 Health Sciences Research Building, 1095 V.A. Drive, Lexington, KY 40536, USA.
Hideyuki J MajimaDepartment of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan ; Department of Space Environmental Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan.
University of Kentucky · USKagoshima University · JPThe Heart Research Institute · AUUniversity of Tsukuba · JP

Funding

Center for Biomedical Research Excellence in the Molecular Basis of Human DiseaseP20GM103486 · NIGMS · UNIVERSITY OF KENTUCKY · PI LOUIS HERSH, LOUIS HERSH LOUIS HERSH · 2012 to 2013
$4.2M
LTQ Orbitrap XL ETD mass spectrometerS10RR029127 · NCRR · UNIVERSITY OF KENTUCKY · PI ZHU, HAINING · 2010 to 2010
$908k
NCRR NIH HHS S10 RR029127NIGMS NIH HHS P20 GM103486
6 · The paper itself

Abstract

It has been demonstrated that cancer cells are under high levels of oxidative stress and express high levels of Manganese superoxide dismutase (MnSOD) to protect themselves and support the anabolic metabolism needed for growth and cell motility. The aim of this study was to identify proteins that may have a correlation with invasion and redox regulation by mitochondrial reactive oxygen species (ROS). MnSOD scavenges superoxide anions generated from mitochondria and is an important regulator of cellular redox status. Oxidative posttranslational modification of cysteine residues is a key mechanism that regulates protein structure and function. We hypothesized that MnSOD regulates intracellular reduced thiol status and promotes cancer invasion. A proteomic thiol-labeling approach with 5-iodoacetamidofluorescein was used to identify changes in intracellular reduced thiol-containing proteins. Our results demonstrate that overexpression of MnSOD maintained the major structural protein, actin, in a reduced state, and enhanced the invasion ability in gastric mucosal cancer cells, RGK1. We also found that the expression of Talin and S100A4 were increased in MnSOD-overexpressed RGK1 cells. Moreover, Talin bound not only with actin but also with S100A4, suggesting that the interaction of these proteins may, in part, contribute to the invasive ability of rat gastric cancer.

Indexed as

actin binding proteincancer invasionMnSODreduced form of actinROS

Identifiers

PMID26236095
PMCPMC4512892
OpenAlexW1698981897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.